Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Surprisingly Profitable Bank Stocks with Insider Purchases

Between August and early December financial stocks underperformed the market by more than 5 percentage points. The trend seems to have reversed since the beginning of December. Financial Select Sector SPDR (XLF) outperformed the SPY by more than 3 percentage points during the past two months. Last week KBW analyzed the fourth quarter earnings of 131 banks. Sixty two percent of the banks met or exceeded consensus estimates. There is a tremendous improvement on the earnings side for both small and large cap banks. Operating earnings per share increased 53% year over year for large caps, and 48% for small caps. Operating earnings per share at large banks increased 5% over the previous quarter, which explains XLF’s recent performance. The decline in lending finally stopped in the fourth quarter, whereas return on equity kept improving by an additional 13 bps over the previous quarter.

Cost of doing business is also improving. The ratio of non-performing assets declined by 10 bps during the past quarter, currently standing at 3.33%. Not surprisingly, banks with TARP performed worse than healthier banks. Their non-performing asset ratio was 4.66%. The median ROE for TARP banks was 1.40% vs. the industry ratio of 5.42%. Considering large banks like Citigroup (C) and Bank of America (BAC) are free from government ownership, they should be doing well compared to last year. Last month, Second Curve’s Tom Brown, a hedge fund focusing on financial companies, was bullish about JP Morgan (JPM) as well. Investors who prefer to diversify should also consider KBW High Dividend Yield Financial Portfolio (KBWD), Regional Bank HOLDRs (RKH), iShares Dow Jones US Financial Sector (IYF), iShares Regional Banks (IAT), Vanguard Financials ETF (VFH) or iShares Global Financials (IXG). We don’t like using leveraged ETFs such as Direxion Daily Financial Bear 3X Shares (FAZ) or Direxion Daily Financial Bull 3X (FAS) due to their hidden costs.

First Niagara Financial Group Inc. (NASDAQ:FNFG)

Insider Monkey, your source for free insider trading data, tracks insider transactions in banking stocks. We believe insider purchases in smaller banks are a strong indicator about the health and future prospects of banks. This is especially true when there are several insiders purchasing around the same time. We compiled the list of financial stocks that have at least two insider purchases and managed to meet or exceed consensus earnings estimates:

1. National Penn Bancshares (NPBC): The company posted 10 cents per share earnings (excluding special items) during the fourth quarter vs. a $2.25 per share loss a year ago. Analysts were expecting 7 cents per share. The company reported a 44% increase in revenue compared to a year ago. Revenue was $21.9 Million.

2. First Niagara Financial Group (FNFG): First Niagara posted 24 cents per share vs. consensus earnings of 23 cents per share.  The company also increased its quarterly dividend to 16 cents, yielding 4.4%.

3. Huntington Bancshares (HBAN): Excluding a one-time 7 cents per share charge related to TARP repayment, Huntington managed to beat the consensus earnings estimates. Huntington was the second best performer in 2010 in the KBW Bank Index, returning 88%.

4. Bank of Hawaii (BOH): Bank of Hawaii reported net income of 84 cents per share during the fourth quarter, beating analyst estimates of 70 cents per share. This is one of the stocks insiders were buying like crazy at the end of January.

5. JP Morgan (JPM): JPM managed to beat the analysts’ $1 per share estimates by delivering $1.12 per share in net income. David C. Novak, the CEO of YUM Brands and also a member of JPM’s board of directors, purchased more than 100,000 shares of JPM.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!